Wenbin Jiang, President and CEO at Cytek Biosciences, Inc. (CTKB), sold 30,000 shares at $11.86 ($237K) on 2022-12-07, disclosed to the SEC on 2022-12-09.
Open-market sale of $237k CTKB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $11.86 | 20,000 | $237K | 100.0% |
| Total | $7.91 avg | 30,000 | $237K | 100% |
| Filing → |
| CTKB | SELL | 2023-09-08 | $137K | — | Filing → |
| CTKB | SELL | 2023-08-08 | $362K | — | Filing → |
| CTKB | SELL | 2023-07-07 | $170K | — | Filing → |